Company profile

Ticker
VXRT
Exchange
Website
CEO
Andrei Floroiu
Employees
Incorporated
Location
Fiscal year end
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., Nabi Biopharmaceuticals, Nabi, Nabi Biopharmaceuticals, North American Biologicals Inc
SEC CIK
IRS number
591212264

VXRT stock data

(
)

Calendar

6 Aug 20
8 Aug 20
31 Dec 20

News

Company financial data Financial data

Quarter (USD) Jun 20 Mar 20 Dec 19 Sep 19
Revenue 523K 2.9M 3.92M 454K
Net income -8.98M -1.3M -6.41M -5.26M
Diluted EPS -0.12 -0.02 -0.13 -0.32
Net profit margin -1716% -44.69% -164% -1159%
Operating income -8.53M -694K -5.63M -4.71M
Net change in cash 14.53M 16.35M -6.03M 3.3M
Cash on hand 44.39M 29.86M 13.51M 19.54M
Cost of revenue
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 11
Revenue 9.86M 4.16M 5.84M 14.84M
Net income -18.65M -18.01M -9.58M -4.53M
Diluted EPS -0.86 -2.9 -91.65
Net profit margin -189% -433% -164% -30.54%
Operating income -15.79M -21.76M -10.02M -9.76M
Net change in cash 2.07M 9.87M -55.95M 3.96M
Cash on hand 13.51M 11.44M 1.57M 57.52M
Cost of revenue 1.46M

Financial data from Vaxart earnings reports

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
29 Jun 20 Armistice Capital Common Stock Sell Dispose S No 0 0 0 145,523
29 Jun 20 Armistice Capital Common Stock Sell Dispose S No 8.29 9,385,386 77.8M 145,523
29 Jun 20 Armistice Capital Common Stock Aquire X No 0 0 0 9,530,909
29 Jun 20 Armistice Capital Common Stock Aquire X No 1.1 4,090,909 4.5M 9,530,909
29 Jun 20 Armistice Capital Warrants Common Stock Dispose X No 1.1 0 0 0
29 Jun 20 Armistice Capital Warrants Common Stock Dispose X No 1.1 4,090,909 4.5M 0
26 Jun 20 Armistice Capital Common Stock Sell Dispose S No 0 0 0 5,440,000
26 Jun 20 Armistice Capital Common Stock Sell Dispose S No 10.38 18,226,667 189.19M 5,440,000
26 Jun 20 Armistice Capital Common Stock Aquire X No 0 0 0 23,666,667
26 Jun 20 Armistice Capital Common Stock Aquire X No 0.3 16,666,667 5M 23,666,667
41.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 38 21 +81.0%
Opened positions 19 3 +533.3%
Closed positions 2 3 -33.3%
Increased positions 8 4 +100.0%
Reduced positions 2 2
13F shares
Current Prev Q Change
Total value 78.05M 12.91M +504.6%
Total shares 30.39M 26.82M +13.3%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Armistice Capital 25.2M $44.6M 0.0%
Renaissance Technologies 2.17M $3.85M +58.7%
Vanguard 644.54K $1.14M +1840.1%
BLK BlackRock 517.63K $916K +1181.0%
Hussman Strategic Advisors 500K $885K NEW
QS Investors 377.75K $669K NEW
Geode Capital Management 338.44K $599K +656.7%
Bank Julius Baer & Co. Ltd, Zurich 242.76K $432K NEW
NTRS Northern Trust 85.55K $152K NEW
Harvest Investment Services 49.86K $88K NEW
Largest transactions
Shares Bought/sold Change
Renaissance Technologies 2.17M +803.95K +58.7%
Vanguard 644.54K +611.32K +1840.1%
Hussman Strategic Advisors 500K +500K NEW
BLK BlackRock 517.63K +477.22K +1181.0%
QS Investors 377.75K +377.75K NEW
Geode Capital Management 338.44K +293.71K +656.7%
Bank Julius Baer & Co. Ltd, Zurich 242.76K +242.76K NEW
NTRS Northern Trust 85.55K +85.55K NEW
Harvest Investment Services 49.86K +49.86K NEW
UBS UBS 12.9K -49.83K -79.4%
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: abetting, abnormally, affirming, aiding, al, anniversary, arena, assign, ATM, Attwill, bear, Carlo, CDMO, chosen, coating, complaint, complement, County, duty, economy, enrichment, equivalent, facilitate, fiduciary, Filer, GMP, Godfrey, headcount, inconvenient, intervening, intrinsic, KindredBio, lawsuit, LP, lyophilization, manipulated, marketplace, Mateo, Memorandum, Monte, nonrenewal, outsized, partnership, primate, purported, ramp, regional, reliant, resolution, revocation, Simulation, Speed, stable, Sterilflow, strictly, temperature, tranche, turn, unjust, unoccupied, unprecedented, upgrade, VAAST, Warp, waste
Removed: allocate, calendar, capture, deployed, ensure, identifying, remain, reviewed, separately, specific, tied, understand, unforeseen